POCKIT™ Central SARS-CoV-2 (orf 1ab) Premix Reagent is intended for use with POCKIT™ Central system. The assay, targeting orf 1ab gene, is an in vitro diagnostic1 molecular assay for qualitative detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA in oropharyngeal swab samples from patients suspected of SARS-CoV-2 infection (COVID-19) during the acute phase.
1Not U.S. FDA cleared or approved yet.| Overall agreement..........................................97.0% |
| Positive agreement.........................................96.8% |
| Negative agreement.......................................97.1% |
*Compared to a SARS-CoV-2 real-time PCR assay
| Reagent |
|---|
| Product Name | cat. No. | Specifications |
| POCKIT™ Central SARS-CoV-2 (orf 1ab) Premix Reagent | apcr-123 | 24 tests/set including: - Cartridge Set (B) for nucleic acid extraction and liquid transfer - SARS-CoV-2 Premix Reagent
for iiPCR |
Other Products You May Be Interested
| Instrument |
|---|
| Product Name | cat. No. | Specifications |
| POCKIT™ Central Nucleic Acid Analyzer | apcc-1i | Throughput: 1-8 samples |
| Positive Control |
|---|
| Product Name | cat. No. | Specifications |
| POCKIT™ Central SARS-CoV-2 (orf 1ab) P(+) Control Reagent | apcr-123std | 4 tests/set |